Duke university health system
Durham, North Carolina, 27707, United States
NCT Number: NCT03960619
The purpose of the study is to assess the feasibility, acceptability, and efficacy of a novel mHealth behavioral intervention to enable HCT patients to effectively cope with symptoms to improve their ability to engage in physical activity that can improve physical disability. Our interdisciplinary team (psychiatry, hematology/oncology, occupational therapy) proposes a single arm pilot trial (N=20) to test a hybrid in-person and mHealth (video-conferencing, symptoms/activity monitoring, personalized feedback via text) HCT Coping Skills Training for Symptom Management and Daily Steps (CST Step-Up) intervention. CST Step-Up will provide patients with coping skills training and activity coaching sessions to enhance their ability to cope with symptoms that interfere with activity.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Interventional
Not applicable
Durham, North Carolina, 27707, United States
Our group developed a mHealthpain coping skills training program for HCT patients and found in a small pilot trial (R21) that improved pain coping led to increased daily activity and reduced physical disability. However, fatigue and distress were also barriers to physical activity.
We propose to assess the feasibility, acceptability, and outcome patterns suggesting efficacy of a novel mHealth behavioral intervention to enable HCT patients to effectively cope with symptoms to improve their ability to engage in physical activity that can improve physical disability.Our interdisciplinary team (psychiatry, hematology/oncology, occupational therapy) is conducting a single arm pilot trial (N=20) to test a hybrid in-person and mHealth (video-conferencing, symptoms/activity monitoring, personalized feedback via text) HCT Coping Skills Training for Symptom Management and Daily Steps (CST Step-Up) intervention. CST Step-Up will provide patients with coping skills training and activity coaching sessions to enhance their ability to cope with symptoms that interfere with activity.
Aim 1:Use a single arm pilot trial (N=20) to examine the feasibility and acceptability of the CST Step-Up protocol. Feasibility will be assessed via (a) study accrual, (b) adherence to the study protocol (intervention and assessments), and (c) retention (% completing the study).
H1:Feasibility will be determined by meeting targeted study accrual (20 patients 15 months), >80% adherence to the protocol, and <20% attrition. Acceptability will be demonstrated by 80% of participants reporting satisfaction with the intervention.
Aim 2:Examine outcome patterns suggesting the efficacy of the CST Step-Up protocol for improving physical disability and other important outcomes.
H2:Pre-and post-intervention differences will be examined with simple t-tests to evaluate patterns suggesting intervention efficacy on measures of physical disability (self-report, 6-min walk test), pain, fatigue, distress, physical activity (daily steps), and self-efficacy for symptom management.
Confirmed hypotheses would provide the first demonstration of the feasibility, acceptability, and positive impact of a hybrid in-person and mHealth coping skills training and activity coaching intervention that reduces physical disability by concurrently and synergistically decreasing symptom burden and increasing physical activity. This project has the potential to lead to future research (e.g., R01) that can redesign existing modes of behavioral intervention delivery, improve continuity and coordination of care, and ultimately enhance patient outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
We aim to test a combined coping skills training and activity coaching protocol that: first, is feasible and acceptable, and second, improves physical disability, as well as pain, fatigue, distress, and physical activity in HCT patients. We propose a novel intervention protocol that uses a hybrid in-person and mHealth intervention delivery model.
Time frame: 15 months
Accrual will be indicated by meeting the recruitment goal
Time frame: 15 months
Adherence will be indicated by the proportion successfully completing intervention sessions
Time frame: 15 months
Attrition will be indicated by 80% of consented participants completing the study protocol.
Time frame: 15 months
Acceptability will be indicated by 80% of patients reporting satisfaction with CST Step-Up on the CSQ.
Time frame: assessments at baseline (pre - treatment) and post-intervention at 3-months..
Functional Assessment of Cancer Therapy 7-item physical well-being scale will be used to assess physical disability.
Time frame: assessments at baseline (pre-treatment) and post-intervention at 3-months.
Fatigue will be measured with the PROMIS Adult Fatigue Short Form.
Time frame: assessments at baseline (pre-treatment) and post-intervention at 3-months.
Psychological Distress will be measured with the Brief Symptom Inventory
Time frame: assessments at baseline (pre-treatment) and post-intervention at 3-months.
Self-Efficacy for Symptom Management will be measured with the PROMIS Self-Efficacy for Managing Symptoms Short Form
Time frame: post-intervention at 3-months.
Symptom Monitoring will involve participants using the study phone to provide (text) daily average ratings of Pain, fatigue, and distress on a 0=none to 10=worst imaginable scale. Symptom data will inform personalized feedback via text from the therapist to the CST Step-Up participant.
Time frame: post-intervention at 3-months.
Physical Activity will be measured by asking participants to monitor daily activity as assessed by step count with a wireless activity tracker (e.g., Fitbit) that syncs with assigned study phone.
Duke University
Other
Acronym: CST Step Up
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01315132
Blood Protein Disorders, Cardiovascular Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05690230
Blood Protein Disorders, Bone Marrow Cancer
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT01919619
B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders
Houston, Texas, United States
View Trial DetailsNCT04847050
Blood Protein Disorders, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial Details